Dixomara Vargas

Array ( [id] => 6433467 [patent_doc_number] => 20100152304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING PERIPLANETA AMERICANA OR ITS ETHANOL EXTRACT AND A METHOD OF USING THE SAME FOR TREATING INFLAMMATIONS' [patent_app_type] => utility [patent_app_number] => 12/336675 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5204 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152304.pdf [firstpage_image] =>[orig_patent_app_number] => 12336675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480758 [patent_doc_number] => 20090203715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'NOVEL 2-HETARYLTHIAZOLE-4-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND USE AS PHARMACEUTICALS' [patent_app_type] => utility [patent_app_number] => 12/331028 [patent_app_country] => US [patent_app_date] => 2008-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10984 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203715.pdf [firstpage_image] =>[orig_patent_app_number] => 12331028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5993615 [patent_doc_number] => 20110015268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'PHARMACEUTICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/746052 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1983 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015268.pdf [firstpage_image] =>[orig_patent_app_number] => 12746052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5331347 [patent_doc_number] => 20090111824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'AMIDE LINKED HETEROAROMATIC DERIVATIVES AS MODULATORS OF MGLUR5' [patent_app_type] => utility [patent_app_number] => 12/258169 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7688 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20090111824.pdf [firstpage_image] =>[orig_patent_app_number] => 12258169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564778 [patent_doc_number] => 20090137631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REGULATION OF G- AND/OR GC-RICH NUCLEIC ACID EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/256477 [patent_app_country] => US [patent_app_date] => 2008-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12093 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137631.pdf [firstpage_image] =>[orig_patent_app_number] => 12256477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7818652 [patent_doc_number] => 20120065272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'NOVEL USE OF PANDURATIN DERIVATIVES OR EXTRACT OF KAEMPFERIA PANDURATA COMPRISING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/738591 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9814 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20120065272.pdf [firstpage_image] =>[orig_patent_app_number] => 12738591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6267674 [patent_doc_number] => 20100298396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'MANUFACTURE, COMPOSITIONS AND USES OF COAGULATION FACTOR VIIa MODULATOR' [patent_app_type] => utility [patent_app_number] => 12/738372 [patent_app_country] => US [patent_app_date] => 2008-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25569 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298396.pdf [firstpage_image] =>[orig_patent_app_number] => 12738372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6516673 [patent_doc_number] => 20100216848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'LIQUID PHARMACEUTICAL COMPOSITIONS FOR PARENTERAL ADMINISTRATION OF A SUBSTITUTED AMIDE' [patent_app_type] => utility [patent_app_number] => 12/678783 [patent_app_country] => US [patent_app_date] => 2008-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6522 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216848.pdf [firstpage_image] =>[orig_patent_app_number] => 12678783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6379847 [patent_doc_number] => 20100081862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'Composition and method to modify sperm function and increase male gender ratio in mammals' [patent_app_type] => utility [patent_app_number] => 12/286521 [patent_app_country] => US [patent_app_date] => 2008-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4877 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081862.pdf [firstpage_image] =>[orig_patent_app_number] => 12286521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6391197 [patent_doc_number] => 20100303739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'Highly Concentrated Fatty Alcohol Sulfate Preparation' [patent_app_type] => utility [patent_app_number] => 12/678041 [patent_app_country] => US [patent_app_date] => 2008-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2069 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303739.pdf [firstpage_image] =>[orig_patent_app_number] => 12678041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11229769 [patent_doc_number] => 09456980 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-04 [patent_title] => 'Latanoprost-containing aqueous pharmaceutical composition' [patent_app_type] => utility [patent_app_number] => 12/674962 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5025 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12674962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9250476 [patent_doc_number] => 08614255 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-24 [patent_title] => 'Pulmonary pharmaceutical formulations' [patent_app_type] => utility [patent_app_number] => 12/195878 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11732 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12195878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960576 [patent_doc_number] => 20080275001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'SOLID ORAL DOSAGE FORM CONTAINING AN ENHANCER' [patent_app_type] => utility [patent_app_number] => 12/172707 [patent_app_country] => US [patent_app_date] => 2008-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10718 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20080275001.pdf [firstpage_image] =>[orig_patent_app_number] => 12172707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496469 [patent_doc_number] => 20090264497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'STABLE PHARMACEUTICAL FORMULATION COMPRISING A HMG-COA REDUCTASE INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/172143 [patent_app_country] => US [patent_app_date] => 2008-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3951 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264497.pdf [firstpage_image] =>[orig_patent_app_number] => 12172143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6231814 [patent_doc_number] => 20100184783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY ATHEROSCLEROSIS COMPRISING A MAST CELL INHIBITOR AND A PPAR GAMMA AGONIST' [patent_app_type] => utility [patent_app_number] => 12/452596 [patent_app_country] => US [patent_app_date] => 2008-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18271 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184783.pdf [firstpage_image] =>[orig_patent_app_number] => 12452596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9375843 [patent_doc_number] => 08680107 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Activators and therapeutic applications thereof' [patent_app_type] => utility [patent_app_number] => 12/665473 [patent_app_country] => US [patent_app_date] => 2008-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6168 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12665473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8896936 [patent_doc_number] => 08476458 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-02 [patent_title] => 'Methods and compositions for modulating P300/CBP activity' [patent_app_type] => utility [patent_app_number] => 12/665751 [patent_app_country] => US [patent_app_date] => 2008-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 19373 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12665751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515533 [patent_doc_number] => 20090215840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'METHODS FOR TREATING SCHIZOPHRENIA' [patent_app_type] => utility [patent_app_number] => 12/136099 [patent_app_country] => US [patent_app_date] => 2008-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 13595 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215840.pdf [firstpage_image] =>[orig_patent_app_number] => 12136099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134563 [patent_doc_number] => 20110008465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'SESQUITERPENE FORMULATIONS, KITS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/602382 [patent_app_country] => US [patent_app_date] => 2008-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 16495 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008465.pdf [firstpage_image] =>[orig_patent_app_number] => 12602382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6509698 [patent_doc_number] => 20100210700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'METHODS OF TREATMENT USING INTRAVENOUS FORMULATIONS COMPRISING TEMOZOLOMIDE' [patent_app_type] => utility [patent_app_number] => 12/598012 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17424 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210700.pdf [firstpage_image] =>[orig_patent_app_number] => 12598012 [rel_patent_id] =>[rel_patent_doc_number] =>)